8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 2, 2024 (May 1, 2024)

Cano Health, Inc.

(Exact name of registrant as specified in its charter)

Commission File Number: 001-39289

Delaware	98-1524224
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

9725 NW 117th Avenue, Miami, FL	33178
(Address of principal executive offices)	(Zip Code)

(855) 226-6633

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A common stock, $0.01 par value per share	CANOQ	OTC Pink Marketplace

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

As previously disclosed in a Current Report on Form 8-K filed by the Company on February 5, 2024, on February 4, 2024, Cano Health, Inc. (the “Company”) and certain of its direct and indirect subsidiaries (collectively, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) seeking relief under Chapter 11 of Title 11 of the United States Code (the “Bankruptcy Code”). The Chapter 11 Cases are being jointly administered under Case No. 24-10164. The Debtors continue to operate their business and manage their properties as “debtors-in-possession” under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court. Additional information about the Chapter 11 Cases, including access to Bankruptcy Court documents, is available online at https://www.kccllc.net/CanoHealth, a website administered by Kurtzman Carson Consultants LLC, the Debtors’ Bankruptcy Court-approved third-party bankruptcy claims and noticing agent, and on the docket of the Chapter 11 Cases, which can be accessed via PACER at https://pacer.gov. The information on these websites and docket is not incorporated by reference into, and does not constitute part of, this Current Report on Form 8-K.

Item 8.01 Other Events.

On May 1, 2024, the Company filed with the Bankruptcy Court the monthly operating report for the period beginning March 1, 2024 and ending March 31, 2024 (collectively, the “Monthly Operating Report”). The Monthly Operating Report is attached to this Current Report on Form 8-K (the “Form 8-K”) as Exhibit 99.1 and is incorporated herein by reference in its entirety. This Form 8-K (including the exhibit hereto) will not be deemed an admission as to the materiality of any information filed herewith. The Monthly Operating Report and other filings with the Bankruptcy Court related to the Chapter 11 Cases may be available electronically at https://www.kccllc.net/CanoHealth. Documents and other information available on such website are not part of this Form 8-K and shall not be deemed incorporated by reference into this Form 8-K.

Cautionary Statement Regarding the Monthly Operating Report

The Company cautions investors and potential investors not to place undue reliance upon the information contained in the Monthly Operating Report, which was not prepared for the purpose of providing the basis for an investment decision relating to any of the Company’s securities. The Monthly Operating Report is limited in scope, covers a limited time period and has been prepared solely for the purpose of complying with the Bankruptcy Court’s monthly reporting requirements. The Monthly Operating Report was not audited or reviewed by independent accountants, was not prepared in accordance with generally accepted accounting principles in the United States, is in a format prescribed by applicable bankruptcy laws or rules, and is subject to future adjustment and reconciliation. There can be no assurance that, from the perspective of an investor or potential investor in the Company’s securities, the Monthly Operating Report is complete. The Company has not yet completed its quarter-end financial close processes for the fiscal quarter ended March 31, 2024, as such the information contained in the Monthly Operating Report is based on financial information currently available to the Company, including certain assumptions and estimates by management, and should be considered preliminary. As such, the Company’s actual results for the quarterly period covered in part by the Monthly Operating Report may materially vary from the preliminary results presented in such report. The Monthly Operating Report also contains information for periods which are shorter or otherwise different from those required in the Company’s reports pursuant to the Exchange Act, and such information might not be indicative of the Company’s financial condition or operating results for the period that would be reflected in the Company’s financial statements or in its reports pursuant to the Exchange Act. Results set forth in the Monthly Operating Report should not be viewed as indicative of future results.

Forward Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements relate to future events and involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and could materially affect actual results, performance or achievements. These forward-looking statements generally can be identified by words such as “will,” “shall,” “may,” “anticipates,” “forecasts,” “plans,” “assumes,” “expects,” “seeks,” or other words or phrases of similar import. Such statements include, without limitation, statements regarding: (i) that certain Restructuring Support Agreement between the Company, certain of its direct and indirect subsidiaries and the lenders party thereto, dated as of February 4, 2024 (the “RSA”), the transactions contemplated thereby, and

the expected benefits thereof, including that it will enable the Company to substantially reduce its debt and position the Company to achieve long-term success and maximize value; (ii) the Company’s Chapter 11 Cases, including, without limitation, the Amended Joint Chapter 11 Plan of Reorganization of Cano Health, Inc. and its Affiliated Debtors and the related proposed Disclosure Statement, the outcome of the Chapter 11 Cases and the Company’s expectations as to receipt of and timing for the Bankruptcy Court approvals and the timing of its emergence from the proceedings, as well as the expected benefits of the proceedings, such as that they will strengthen the Company’s financial condition, position the Company to advance its ongoing transformation plan that is designed to significantly reduce costs, enhance productivity, and improve cash flow, ensure patients continue to receive high-quality care across medical centers and improve health outcomes for patients at a lower cost, including the benefits from such activities, including our expectations regarding achieving approximately $290 million of cost reductions by the end of 2024, including approximately $105 million in initiatives currently in process or already implemented (the “Transformation Plan”); (iii) the availability of liquidity from the Company’s debtor-in-possession financing, including the Senior Secured Superpriority Debtor-in-Possession Credit Agreement, dated as of February 7, 2024, and the various conditions to which such debtor-in-possession financing is subject and the risk that these conditions may not be satisfied for various reasons, including for reasons outside of the Company’s control, as well as the Company’s planned uses of such funds, including, without limitation that the new capital will provide sufficient liquidity to support the Company’s ongoing operations throughout the restructuring process; (iv) the Company’s execution of one or more aspects of the Transformation Plan; and (v) the Company’s anticipated performance, operations, financial strength, potential, and prospects for long-term shareholder value creation, anticipated results of operations, including our business strategies, our projected costs, prospects and plans, and other aspects of our operations or operating results. It is uncertain whether any of the events anticipated by the forward-looking statements will occur, or, if any of them do, what impact they will have on our results of operations and financial condition. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others: changes in market or industry conditions, the regulatory environment, competitive conditions, and/or consumer receptivity to our services; changes in our strategy, future operations, prospects and plans; our ability to realize expected financial results, including with respect to patient membership, total revenue and earnings; our ability to predict and control our medical cost ratio; our ability to maintain our relationships with health plans and other key payors; our future capital requirements and sources and uses of cash, including funds to satisfy our liquidity needs; our ability to attract and retain members of management and our Board of Directors; and/or our ability to recruit and retain qualified team members and independent physicians. Actual results may also differ materially from such forward-looking statements for a number of other reasons, including those set forth in our filings with the SEC, including, without limitation, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on April 1, 2024 (the “2023 Form 10-K”), as well as our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that we have filed or will file with the SEC during 2023 and 2024 (which may be viewed on the SEC’s website at http://www.sec.gov or on our website at http://www.investors.canohealth.com/ir-home), as well as reasons including, without limitation, our experiencing delays or difficulties in, and/or unexpected or less than anticipated results from: (i) our efforts to successfully pursue the Chapter 11 Cases; (ii) less than expected benefits from the RSA; (iii) less than expected access to liquidity and greater than anticipated costs and expenses; and/or (iv) less than expected cost reductions and/or any of the other expected benefits from the Transformation Plan, such as due to higher than expected costs and charges to achieve one or more aspects of such plan or delays in achieving such benefits. For a detailed discussion of other risks and uncertainties that could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, please refer to our filings with the SEC, including, without limitation, our 2023 Form 10-K and our other SEC filings noted above. Factors other than those listed above could also cause our results to differ materially from expected results. Forward-looking statements speak only as of the date they are made and, except as required by law, we undertake no obligation or duty to publicly update or revise any forward-looking statement, whether to reflect actual results of operations; changes in financial condition; changes in general U.S. or international economic, industry conditions; changes in estimates, expectations or assumptions; or other circumstances, conditions, developments or events arising after the issuance of this Current Report on Form 8-K. Additionally, the business and financial materials and any other statement or disclosure on or made available through the Company’s websites or other websites referenced herein shall not be incorporated by reference into this Current Report on Form 8-K.

The Company cautions that trading in the Company’s securities during the pendency of the Chapter 11 Cases is highly speculative and poses substantial risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by holders of the Company’s securities in the Chapter 11 Cases. Holders of shares of the Company’s Class A common stock could experience a complete loss on their investment, depending on the outcome of the Chapter 11 Cases.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The exhibits listed on the Exhibit Index are incorporated herein by reference.

Exhibit Index

Exhibit No.	Description
99.1	Cano Health, Inc. Monthly Operating Report for the period ended March 31, 2024
104	Cover page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		CANO HEALTH, INC.
May 2, 2024	By:	/s/ Mark D. Kent
		Mark D. Kent
		Chief Executive Officer

EX-99.1

Exhibit 99.1

UNITED STATES BANKRUPTCY COURT DISTRICT OF Delaware In Re. Cano Health, Inc. § Case No. 24-10164 § § Lead Case No. 24-10164 Debtor(s) § Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 03/31/2024 Petition Date: 02/04/2024 Months Pending: 2 Industry Classification: 6 2 1 1 Reporting Method: Accrual Basis Cash Basis Debtor’s Full-Time Employees (current): 0 Debtor’s Full-Time Employees (as of date of order for relief): 0 Supporting Documentation (check all that are attached): (For jointly administered debtors, any required schedules must be provided on a non-consolidated basis for each debtor) Statement of cash receipts and disbursements Balance sheet containing the summary and detail of the assets, liabilities and equity (net worth) or deficit Statement of operations (profit or loss statement) Accounts receivable aging Postpetition liabilities aging Statement of capital assets Schedule of payments to professionals Schedule of payments to insiders All bank statements and bank reconciliations for the reporting period Description of the assets sold or transferred and the terms of the sale or transfer /s/ Eladio Gil Eladio Gil Signature of Responsible Party Printed Name of Responsible Party 05/01/2024 Date 9725 NW 117th Ave, Miami, FL 33178 Address STATEMENT: This Periodic Report is associated with an open bankruptcy case; therefore, Paperwork Reduction Act exemption 5 C.F.R. § 1320.4(a)(2) applies. UST Form 11-MOR (12/01/2021)

Debtor’s Name Cano Health, Inc. Case No. 24-10164 Part 1: Cash Receipts and Disbursements Current Month Cumulative a. Cash balance beginning of month $40,117 b. Total receipts (net of transfers between accounts) $114,131 $136,179 c. Total disbursements (net of transfers between accounts) $0 $0 d. Cash balance end of month (a+b-c) $154,248 e. Disbursements made by third party for the benefit of the estate $0 $0 f. Total disbursements for quarterly fee calculation (c+e) $0 $0 Part 2: Asset and Liability Status Current Month (Not generally applicable to Individual Debtors. See Instructions.) a. Accounts receivable (total net of allowance) $0 b. Accounts receivable over 90 days outstanding (net of allowance) $0 c. Inventory (Book Market Other (attach explanation)) $0 d Total current assets $0 e. Total assets $0 f. Postpetition payables (excluding taxes) $0 g. Postpetition payables past due (excluding taxes) $0 h. Postpetition taxes payable $0 i. Postpetition taxes past due $0 j. Total postpetition debt (f+h) $0 k. Prepetition secured debt $0 l. Prepetition priority debt $0 m. Prepetition unsecured debt $0 n. Total liabilities (debt) (j+k+l+m) $0 o. Ending equity/net worth (e-n) $0 Part 3: Assets Sold or Transferred Current Month Cumulative a. Total cash sales price for assets sold/transferred outside the ordinary $0 $0 course of business b. Total payments to third parties incident to assets being sold/transferred outside the ordinary course of business $0 $0 c. Net cash proceeds from assets sold/transferred outside the ordinary course of business (a-b) $0 $0 Part 4: Income Statement (Statement of Operations) Current Month Cumulative (Not generally applicable to Individual Debtors. See Instructions.) a. Gross income/sales (net of returns and allowances) $0 b. Cost of goods sold (inclusive of depreciation, if applicable) $0 c. Gross profit (a-b) $0 d. Selling expenses $0 e. General and administrative expenses $3,299,113 f. Other expenses $0 g. Depreciation and/or amortization (not included in 4b) $0 h. Interest $0 i. Taxes (local, state, and federal) $0 j. Reorganization items $0 k. Profit (loss) $-3,299,113 $-3,998,562 UST Form 11-MOR (12/01/2021)

Debtor’s Name Cano Health, Inc. Case No. 24-10164 Part 5: Professional Fees and Expenses Approved Approved Paid Current Paid Current Month Cumulative Month Cumulative a. Debtor’s professional fees & expenses (bankruptcy) Aggregate Total Itemized Breakdown by Firm Firm Name Role i ii iii iv v vi vii viii ix x xi xii xiii xiv xv xvi xvii xviii xix xx xxi xxii xxiii xxiv xxv xxvi xxvii xxviii xxix xxx xxxi xxxii xxxiii xxxiv xxxv xxxvi UST Form 11-MOR (12/01/2021)

Debtor’s Name Cano Health, Inc. Case No. 24-10164 xxxvii xxxvii xxxix xl xli xlii xliii xliv xlv xlvi xlvii xlviii xlix l li lii liii liv lv lvi lvii lviii lix lx lxi lxii lxiii lxiv lxv lxvi lxvii lxviii lxix lxx lxxi lxxii lxxiii lxxiv lxxv lxxvi lxxvii lxxvii UST Form 11-MOR (12/01/2021) 4

Debtor’s Name Cano Health, Inc. Case No. 24-10164 lxxix lxxx lxxxi lxxxii lxxxii lxxxiv lxxxv lxxxvi lxxxvi lxxxvi lxxxix xc xci xcii xciii xciv xcv xcvi xcvii xcviii xcix c ci Approved Approved Paid Current Paid Current Month Cumulative Month Cumulative b. Debtor’s professional fees & expenses (nonbankruptcy) Aggregate Total Itemized Breakdown by Firm Firm Name Role i ii iii iv v vi vii viii ix x xi xii xiii xiv UST Form 11-MOR (12/01/2021) 5

Debtor’s Name Cano Health, Inc. Case No. 24-10164 xv xvi xvii xviii xix xx xxi xxii xxiii xxiv xxv xxvi xxvii xxviii xxix xxx xxxi xxxii xxxiii xxxiv xxxv xxxvi xxxvii xxxvii xxxix xl xli xlii xliii xliv xlv xlvi xlvii xlviii xlix l li lii liii liv lv lvi UST Form 11-MOR (12/01/2021) 6

Debtor’s Name Cano Health, Inc. Case No. 24-10164 lvii lviii lix lx lxi lxii lxiii lxiv lxv lxvi lxvii lxviii lxix lxx lxxi lxxii lxxiii lxxiv lxxv lxxvi lxxvii lxxvii lxxix lxxx lxxxi lxxxii lxxxii lxxxiv lxxxv lxxxvi lxxxvi lxxxvi lxxxix xc xci xcii xciii xciv xcv xcvi xcvii xcviii UST Form 11-MOR (12/01/2021) 7

Debtor’s Name Cano Health, Inc. Case No. 24-10164 xcix c c. All professional fees and expenses (debtor & committees) $0 $0 $0 $0 Part 6: Postpetition Taxes Current Month Cumulative a. Postpetition income taxes accrued (local, state, and federal) $0 $0 b. Postpetition income taxes paid (local, state, and federal) $0 $0 c. Postpetition employer payroll taxes accrued $0 $0 d. Postpetition employer payroll taxes paid $0 $0 e. Postpetition property taxes paid $0 $0 f. Postpetition other taxes accrued (local, state, and federal) $0 $0 g. Postpetition other taxes paid (local, state, and federal) $0 $0 Part 7: Questionnaire—During this reporting period: a. Were any payments made on prepetition debt? (if yes, see Instructions) Yes No b. Were any payments made outside the ordinary course of business Yes No without court approval? (if yes, see Instructions) c. Were any payments made to or on behalf of insiders? Yes No d. Are you current on postpetition tax return filings? Yes No e. Are you current on postpetition estimated tax payments? Yes No f. Were all trust fund taxes remitted on a current basis? Yes No g. Was there any postpetition borrowing, other than trade credit? Yes No (if yes, see Instructions) h. Were all payments made to or on behalf of professionals approved by Yes No N/A the court? i. Do you have: Worker’s compensation insurance? Yes No If yes, are your premiums current? Yes No N/A (if no, see Instructions) Casualty/property insurance? Yes No If yes, are your premiums current? Yes No N/A (if no, see Instructions) General liability insurance? Yes No If yes, are your premiums current? Yes No N/A (if no, see Instructions) j. Has a plan of reorganization been filed with the court? Yes No k. Has a disclosure statement been filed with the court? Yes No l. Are you current with quarterly U.S. Trustee fees as Yes No set forth under 28 U.S.C. § 1930? UST Form 11-MOR (12/01/2021) 8

Debtor’s Name Cano Health, Inc. Case No. 24-10164 Part 8: Individual Chapter 11 Debtors (Only) a. Gross income (receipts) from salary and wages $0 b. Gross income (receipts) from self-employment $0 c. Gross income from all other sources $0 d. Total income in the reporting period (a+b+c) $0 e. Payroll deductions $0 f. Self-employment related expenses $0 g. Living expenses $0 h. All other expenses $0 i. Total expenses in the reporting period (e+f+g+h) $0 j. Difference between total income and total expenses (d-i) $0 k. List the total amount of all postpetition debts that are past due $0 l. Are you required to pay any Domestic Support Obligations as defined by 11 Yes No U.S.C § 101(14A)? m. If yes, have you made all Domestic Support Obligation payments? Yes No N/A Privacy Act Statement 28 U.S.C. § 589b authorizes the collection of this information, and provision of this information is mandatory under 11 U.S.C. §§ 704, 1106, and 1107. The United States Trustee will use this information to calculate statutory fee assessments under 28 U.S.C. § 1930(a)(6). The United States Trustee will also use this information to evaluate a chapter 11 debtor’s progress through the bankruptcy system, including the likelihood of a plan of reorganization being confirmed and whether the case is being prosecuted in good faith. This information may be disclosed to a bankruptcy trustee or examiner when the information is needed to perform the trustee’s or examiner’s duties or to the appropriate federal, state, local, regulatory, tribal, or foreign law enforcement agency when the information indicates a violation or potential violation of law. Other disclosures may be made for routine purposes. For a discussion of the types of routine disclosures that may be made, you may consult the Executive Office for United States Trustee’s systems of records notice, UST-001, “Bankruptcy Case Files and Associated Records.” See 71 Fed. Reg. 59,818 et seq. (Oct. 11, 2006). A copy of the notice may be obtained at the following link: http:// www.justice.gov/ust/eo/rules_regulations/index.htm. Failure to provide this information could result in the dismissal or conversion of your bankruptcy case or other action by the United States Trustee. 11 U.S.C. § 1112(b)(4)(F). I declare under penalty of perjury that the foregoing Monthly Operating Report and its supporting documentation are true and correct and that I have been authorized to sign this report on behalf of the estate. /s/ Eladio Gil Eladio Gil Signature of Responsible Party Printed Name of Responsible Party Chief Financial Officer 05/01/2024 Title Date

Debtor’s Name Cano Health, Inc. Case No. 24-10164 PageOnePartOne PageOnePartTwo PageTwoPartOne PageTwoPartTwo UST Form 11-MOR (12/01/2021) 10

Debtor’s Name Cano Health, Inc. Case No. 24-10164 Bankruptcy1to50 Bankruptcy51to100 NonBankruptcy1to50 NonBankruptcy51to100 UST Form 11-MOR (12/01/2021) 11

Debtor’s Name Cano Health, Inc. Case No. 24-10164 PageThree PageFour UST Form 11-MOR (12/01/2021) 12

IN THE UNITED STATES BANKRUPTCY COURT

FOR THE DISTRICT OF DELAWARE

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -		x
In re	:		Chapter 11
		:
CANO HEALTH, INC., et al.,	:		Case No. 24-10164 (KBO)
		:
		:
Debtors.1	:		(Jointly Administered)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -		x

STATEMENTS OF LIMITATIONS,

METHODOLOGY, AND DISCLAIMERS REGARDING

MONTHLY OPERATING REPORT FOR THE PERIOD

FROM MARCH 1, 2024 THROUGH MARCH 31, 2024

Introduction

Cano Health, Inc. and certain of its subsidiaries, as debtors and debtors in possession (collectively, the “Debtors”) in the above-captioned chapter 11 cases (the “Chapter 11 Cases”) have prepared and filed the attached Monthly Operating Report (this “MOR”) for the period including March 1, 2024 through March 31, 2024 (the “Reporting Period”) in the United States Bankruptcy Court for the District of Delaware (the “Court”). The Debtors have prepared this MOR with the assistance of their advisors and professionals solely for the purpose of complying with the reporting requirements applicable in the Chapter 11 Cases. 

Although the Debtors generally prepare their financial statements on a consolidated basis, this MOR has been prepared on an entity-by-entity basis (excluding most intercompany eliminations) for each of the Debtors. This MOR is unaudited, limited in scope, and does not purport to represent financial information prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), nor is it in accordance with federal or state securities laws or other applicable non-bankruptcy law or in lieu of complying with any periodic reporting requirements thereunder. This MOR is not intended to fully reconcile to the consolidated financial information prepared by the Debtors. Information contained in this MOR is derived from the Debtors’ books and records, but does not reflect in all circumstances the presentation for U.S. GAAP or U.S. Securities and Exchange Commission reporting purposes. In order to comply with their obligations to provide MORs during these Chapter 11 Cases, the Debtors have prepared this MOR using the best information presently available to them, which has been collected, maintained, and prepared in accordance with their historical accounting practices, prior to consolidating and eliminating entries. The results of operations, financial position, and schedule of receipts and disbursements contained herein are not necessarily indicative of results that may be expected for any period other the Reporting Period, and may not necessarily reflect the Debtors’ future consolidated results of operations, financial position, and schedule of receipts and disbursements. The Debtors caution readers not to place undue reliance upon this MOR. There can be no assurance that such information is complete, and this MOR may be subject to revision.

¹  The last four digits of Cano Health, Inc.’s tax identification number are 4224. A complete list of the Debtors in the chapter 11 cases may be obtained on the website of the Debtors’ claims and noticing agent at https://www.kccllc.net/CanoHealth. The Debtors’ mailing address is 9725 NW 117th Avenue, Miami, Florida 33178.

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 1

Interest in Subsidiaries and Affiliates

Cano Health, Inc. (“CHI”) owns the equity interests in Primary Care (ITC) Intermediate Holdings, LLC (“PCIH”) through 67.72% economic interests and 100% voting interests. PCIH owns 100% of the membership interests in Cano Health, LLC (“CH LLC”). CH LLC directly or indirectly owns 100% of the membership interests in all remaining Debtors.

In order for the Debtors to deliver healthcare services to patients in certain markets, the Debtors contracted with entities (the “Physicians Groups”) that enabled the Debtors to employ healthcare providers to contract with managed care payors. Each Physician Group contracted with the Company through a Management Services Agreement (“MSA”), which allowed such Physician Groups to provide certain services. Prior to the Petition Date, the Debtors terminated such MSAs and have sold all or substantially all of the assets of the Physicians Groups.

Notwithstanding such agreements having been terminated, the MOR for CH LLC provides financial figures for the Physician Groups, which include Cano Health Texas, PLLC, Cano Health Nevada, PLLC, Cano Health California, PC, CHC Provider Network, PC and Cano Health Illinois, PLLC.

Reservation of Rights

This MOR is limited in scope, covers a limited time period, and has been prepared solely for the purpose of complying with the monthly reporting requirements of the Debtors’ Chapter 11 Cases. The unaudited financial information has been derived from the Debtors’ books and records. The information presented herein has not been subject to all procedures that typically would be applied to financial information in accordance with U.S. GAAP. Upon the application of such procedures, the Debtors believe that the financial information could be subject to material change. The information furnished in this MOR includes normal recurring adjustments but does not include all of the adjustments that typically would be made for interim financial information presented in accordance with U.S. GAAP.

Although the Debtors made commercially reasonable efforts to ensure the accuracy and completeness of this MOR, inadvertent errors and omissions may occur. Accordingly, the Debtors hereby reserve all of their rights to dispute the nature, validity, status, enforceability, or executory natures of any claim amount, agreement, representation, or other statement set forth in this MOR. Further, the Debtors reserve the right to amend or supplement this MOR in all respects, as may be necessary and appropriate, but shall be under no obligation to do so. Nothing contained in this MOR shall constitute a waiver of any of the Debtors’ rights or an admission with respect to the Chapter 11 Cases.

The Debtors’ management prepared this MOR with the assistance of their advisors, and relied on financial data derived from their books, records, and historical financial statements that were available at the time of this MOR’s preparation. Eladio Gil, the Debtors’ Chief Financial Officer, has signed each MOR. Mr. Gil is an authorized signatory for each of the Debtors. In reviewing and signing this MOR, Mr. Gil necessarily has relied upon the efforts, statements, advice, and representations of various personnel employed by the Debtors and their advisors. Mr. Gil has not (and could not have) personally verified the accuracy of each statement, representation, and answer contained in each MOR.

MOR Form

Part 1: Cash Receipts and Disbursements

Reported cash receipts may include intercompany Debtor-to-Debtor transactions given the nature of the Debtors’ cash management system and the reporting requirements for this MOR. Reported cash disbursements exclude any intercompany Debtor-to-Debtor transactions and only represent payments made to external third

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 2

parties. As a result, the estimated disbursements reported on Part 1 of the MOR may not agree with the Debtors’ bank statements or the Debtors’ books and records. Reconciling differences will exist between bank statement balances and balance sheet cash balances due to routine timing differences between payment execution in the Debtors’ financial system and disbursement of funds from Debtor bank accounts.

Part 2: Asset and Liability Status

Please refer to the “Introduction,” “Interest in Subsidiaries and Affiliates” and “Reservation of Rights” notes above for information about presentation and limitations that may exist in the MOR.

Postpetition payables primarily consists of trade payables balances.

Part 3: Assets Sold or Transferred

No such transactions or activities occurred during the Reporting Period. Please refer to the “Introduction,” “Interest in Subsidiaries and Affiliates” and “Reservation of Rights” notes above for information about presentation and limitations that may exist in the MOR. 

Part 4: Income Statement (Statement of Operations)

Please refer to the “Introduction,” “Interest in Subsidiaries and Affiliates” and “Reservation of Rights” notes above for information about presentation and limitations that may exist in the MOR.

Part 5: Professional Fees and Expenses

The Debtors did not make any payments to any restructuring professionals or committee professionals (whether retained or anticipated to be retained) during the Reporting Period.

Part 6: Postpetition Taxes

In the ordinary course of business, the Debtors are obligated to pay certain taxes and governmental fees. On March 5, 2024 (outside the Reporting Period), the Court entered the Final Order Pursuant to 11 U.S.C. §§ 105(a), 363(b), 507(a), and 541(d) (I) Authorizing Debtors to Pay Prepetition Taxes and Fees, and (II) Granting Related Relief [Docket No. 242] authorizing, but not directing, the Debtors to, among other things, pay Taxes and Fees that arise or accrue in the ordinary course of business on a postpetition basis consistent with prepetition practices. The Debtors believe that they are current with respect to any postpetition Taxes and Fees that have come due.

Part 7(g): Postpetition Borrowing

On March 6, 2024, the Court entered the Final Order Pursuant to 11 U.S.C. §§ 105, 361, 362, 363, 364, 507, and 552 and Fed. R. Bankr. P. 2002, 4001, 6003, 6004, and 9014 for (I) Authority to (A) Obtain Postpetition Financing, (B) Use Cash Collateral (C) Grant Liens and Provide Superpriority Administrative Expense Status, (D) Grant Adequate Protection, and (E) Modify the Automatic Stay, and (II) Related Relief [Docket No. 271] authorizing the Debtors to (i) obtain postpetition financing (the “DIP Financing”) to fund the costs of implementing the Debtors’ restructuring in the form of a superpriority senior secured multiple draw term loan credit facility in the aggregate principal amount of $150,000,000, and (ii) the Debtors’ use of cash collateral. During the Reporting Period, the Debtors drew $22,000,000 under the DIP Financing.

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 3

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Cash Receipts and Disbursements Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10164		24-10165		24-10166		24-10167			24-10168		24-10169		24-10170		24-10171		24-10172		24-10173
	Cano Health, Inc.		Primary Care (ITC) Intermediate Holdings, LLC		Complete Medical Billing and Coding Services, LLC		Cano Health, LLC			Cano Health of Puerto Rico LLC		CHPR MSO LLC		Cano Health of Florida, LLC		Cano Health CA1 MSO, LLC		Physicians Partners Group Merger, LLC		Cano Health Nevada Network, LLC
Receipts		114		—		—		16,431			—		—		—		—		93		—
DIP Funds Received		—		—		—		22,000			—		—		—		—		—		—
Total Receipts		114		—		—		38,431			—		—		—		—		93		—
Disbursements
Operating Disbursements		—		—		—		3,234			—		—		—		—		—		—
Operating Disbursements (Auto Debits)		—		—		—		1,364			—		—		—		—		—		—
Operating Professional Costs		—		—		—		2,151			—		—		—		—		—		—
Rent		—		—		—		3,085			—		—		—		—		—		—
Payroll & Benefits		—		—		—		15,813			—		—		—		—		—		—
Pharmacy Rx Costs		—		—		—		—			—		—		—		—		—		—
PPG		—		—		—		—			—		—		—		—		—		—
Provider Payments		—		—		—		1,528			—		—		—		—		31		—
Loan Interest		—		—		—		805			—		—		—		—		—		—
Intact Collateral		—		—		—		11,971			—		—		—		—		—		—
KCC - DIP Escrow		—		—		—		11,986			—		—		—		—		—		—
Transaction Fees and Other Disbursements		—		—		—		—			—		—		—		—		—		—
Total Disbursements		—		—		—		51,937			—		—		—		—		31		—
Net Cash Flow	$	114	$	—	$	—	$	(13,506	)	$	—	$	—	$	—	$	—	$	62	$	—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 4

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Cash Receipts and Disbursements (continued) Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10174		24-10175		24-10176		24-10177		24-10178		24-10179		24-10180		24-10181		24-10182		24-10183
	Comfort Pharmacy 2, LLC		Cano Medical Center of West Florida, LLC		Cano Occupational Health, LLC		CH Dental Administrative Services LLC		American Choice Healthcare, LLC		Physicians Partners Group Puerto Rico, LLC (FL)		DGM MSO, LLC		Cano PCP Wound Care, LLC		Cano Research LLC		Cano Personal Behavior LLC
Receipts		853		0		—		—		4,931		—		476		—		—		—
DIP Funds Received		—		—		—		—		—		—		—		—		—		—
Total Receipts		853		0		—		—		4,931		—		476		—		—		—
Disbursements
Operating Disbursements		—		—		—		—		—		—		—		—		—		—
Operating Disbursements (Auto Debits)		—		—		—		—		—		—		—		—		—		—
Operating Professional Costs		—		—		—		—		—		—		—		—		—		—
Rent		—		—		—		—		—		—		—		—		—		—
Payroll & Benefits		—		—		—		—		—		—		—		—		—		—
Pharmacy Rx Costs		828		—		—		—		—		—		—		—		—		—
PPG		—		—		—		—		—		—		—		—		—		—
Provider Payments		—		—		—		—		128		—		205		—		—		—
Loan Interest		—		—		—		—		—		—		—		—		—		—
Intact Collateral		—		—		—		—		—		—		—		—		—		—
KCC - DIP Escrow		—		—		—		—		—		—		—		—		—		—
Transaction Fees and Other Disbursements		—		—		—		—		—		—		—		—		—		—
Total Disbursements		828		—		—		—		128		—		205		—		—		—
Net Cash Flow	$	25	$	0	$	—	$	—	$	4,803	$	—	$	272	$	—	$	—	$	—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 5

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Cash Receipts and Disbursements (continued) Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10184		24-10185		24-10186		24-10187		24-10188		24-10189		24-10190		24-10191		24-10192		24-10193
	Cano PCP MSO, LLC		Physicians Partners Group Puerto Rico, LLC (PR)		Cano HP MSO, LLC		Cano PCP, LLC		Orange Healthcare Administration, LLC		ACH Management Services, LLC		Physicians Partners Group of FL, LLC		Cano Behavior Health LLC		PPG Puerto Rico Blocker, Inc.		Orange Care Group South Florida Management Services Organization, LLC
Receipts		—		—		171		36		—		—		31		—		—		—
DIP Funds Received		—		—		—		—		—		—		—		—		—		—
Total Receipts		—		—		171		36		—		—		31		—		—		—
Disbursements
Operating Disbursements		—		—		—		—		—		—		—		—		—		—
Operating Disbursements (Auto Debits)		—		—		—		—		—		—		—		—		—		—
Operating Professional Costs		—		—		—		—		—		—		—		—		—		—
Rent		—		—		—		—		—		—		—		—		—		—
Payroll & Benefits		—		—		—		—		—		—		—		—		—		—
Pharmacy Rx Costs		—		—		—		—		—		—		—		—		—		—
PPG		—		—		—		—		—		—		—		—		—		—
Provider Payments		—		—		—		—		—		—		—		—		—		—
Loan Interest		—		—		—		—		—		—		—		—		—		—
Intact Collateral		—		—		—		—		—		—		—		—		—		—
KCC - DIP Escrow		—		—		—		—		—		—		—		—		—		—
Transaction Fees and Other Disbursements		—		—		—		—		—		—		—		—		—		—
Total Disbursements		—		—		—		—		—		—		—		—		—		—
Net Cash Flow	$	—	$	—	$	171	$	36	$	—	$	—	$	31	$	—	$	—	$	—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 6

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Cash Receipts and Disbursements (continued) Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10194		24-10195		24-10196		24-10197		24-10198			24-10199		24-10200		24-10201		24-10202		24-10203
	Cano Belen, LLC		Cano Health Illinois Network, LLC		Orange Accountable Care Organization of South Florida LLC		Cano Health New Mexico LLC		Cano Pharmacy, LLC			Orange Accountable Care Organization, LLC		IFB Pharmacy, LLC		American Choice Commercial ACO, LLC		Belen Pharmacy Group, LLC		Orange Care IPA of New York, LLC
Receipts		2,593		—		931		1		2,013			—		0		131		0		—
DIP Funds Received		—		—		—		—		—			—		—		—		—		—
Total Receipts		2,593		—		931		1		2,013			—		0		131		0		—
Disbursements
Operating Disbursements		—		—		—		—		—			—		—		—		—		—
Operating Disbursements (Auto Debits)		—		—		—		—		—			—		—		—		—		—
Operating Professional Costs		—		—		—		—		—			—		—		—		—		—
Rent		—		—		—		—		—			—		—		—		—		—
Payroll & Benefits		—		—		—		—		—			—		—		—		—		—
Pharmacy Rx Costs		—		—		—		—		2,050			—		—		—		—		—
PPG		—		—		—		—		—			—		—		—		—		—
Provider Payments		—		—		—		—		—			—		—		—		—		—
Loan Interest		—		—		—		—		—			—		—		—		—		—
Intact Collateral		—		—		—		—		—			—		—		—		—		—
KCC - DIP Escrow		—		—		—		—		—			—		—		—		—		—
Transaction Fees and Other Disbursements		—		—		—		—		—			—		—		—		—		—
Total Disbursements		—		—		—		—		2,050			—		—		—		—		—
Net Cash Flow	$	2,593	$	—	$	931	$	1	$	(37	)	$	—	$	0	$	131	$	0	$	—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 7

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Cash Receipts and Disbursements (continued) Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10204		24-10205		24-10206		24-10207		24-10208		24-10209		24-10210		24-10211
	University Health Care Pharmacy, LLC		Orange Care IPA of New Jersey, LLC		Cano Health New York, IPA, LLC		Total Care ACO, LLC		Clinical Research of Hollywood, P.A.		Cano Health CA1, LLC		Cano Health Illinois 1 MSO, LLC		Solis Network Solutions, LLC
Receipts		659		—		—		—		—		—		—		—
DIP Funds Received		—		—		—		—		—		—		—		—
Total Receipts		659		—		—		—		—		—		—		—
Disbursements
Operating Disbursements		—		—		—		—		—		—		—		—
Operating Disbursements (Auto Debits)		—		—		—		—		—		—		—		—
Operating Professional Costs		—		—		—		—		—		—		—		—
Rent		—		—		—		—		—		—		—		—
Payroll & Benefits		—		—		—		—		—		—		—		—
Pharmacy Rx Costs		644		—		—		—		—		—		—		—
PPG		—		—		—		—		—		—		—		—
Provider Payments		—		—		—		—		—		—		—		—
Loan Interest		—		—		—		—		—		—		—		—
Intact Collateral		—		—		—		—		—		—		—		—
KCC - DIP Escrow		—		—		—		—		—		—		—		—
Transaction Fees and Other Disbursements		—		—		—		—		—		—		—		—
Total Disbursements		644		—		—		—		—		—		—		—
Net Cash Flow	$	15	$	—	$	—	$	—	$	—	$	—	$	—	$	—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 8

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Balance Sheets   Case No: 24-10164 as of March 31, 2024 $ in thousands

Case Number	24-10164			24-10165		24-10166		24-10167			24-10168			24-10169		24-10170			24-10171			24-10172			24-10173
Entity	Cano Health, Inc.			Primary Care (ITC) Intermediate Holdings, LLC		Complete Medical Billing and Coding Services, LLC		Cano Health, LLC			Cano Health of Puerto Rico LLC			CHPR MSO LLC		Cano Health of Florida, LLC			Cano Health CA1 MSO, LLC			Physicians Partners Group Merger, LLC			Cano Health Nevada Network, LLC
Assets
Current assets:
Cash, cash equivalents and restricted cash		—			—		—		135,145			103			—		—			—			179			—
Accounts receivable, net of unpaid service provider costs		—			—		—		54,123			—			—		—			—			—			—
Equity securities at fair value		—			—		—		1,400			—			—		—			—			—			—
Prepaid expenses and other current assets		—			—		—		18,054			(0	)		—		(2	)		(2	)		—			—
Total current assets		—			—		—		208,721			103			—		(2	)		(2	)		179			—
Property and equipment, net		—			—		—		47,392			—			—		—			1			—			—
Operating lease right of use assets		—			—		—		60,408			5			—		—			—			—			—
Goodwill		—			—		—		(0	)		—			—		—			—			—			—
Payor relationships, net		—			—		—		517,758			—			—		—			—			—			—
Other intangibles, net		—			—		—		160,913			—			—		—			—			—			—
Other assets		(0	)		—		—		4,174			—			—		—			—			—			—
Total Assets		(0	)		—		—		999,366			107			—		(2	)		(1	)		179			—
Liabilities and stockholder’s equity
Current liabilities:
Accounts payable and accrued expenses		—			—		—		132,619			(0	)		—		(0	)		—			—			—
Current portion of notes payable		—			—		—		1,416,909			—			—		—			—			—			—
Current portion of finance lease liabilities		—			—		—		2,703			—			—		—			—			—			—
Current portion due to seller		—			—		—		48,240			—			—		—			—			—			—
Current portion of operating lease liabilities		—			—		—		15,841			7			—		—			16			—			—
Other current liabilities		145			—		—		77,987			—			—		—			—			—			—
Intercompany		(1,186,706	)		—		—		1,147,284			373			—		44			2,338			1,794			—
Total current liabilities		(1,186,561	)		—		—		2,841,583			380			—		44			2,354			1,794			—
Notes payable, net of current portion and debt issuance costs		—			—		—		(0	)		—			—		—			—			—			—
Long term portion of operating lease liabilities		—			—		—		62,002			5			—		—			—			—			—
Due to seller, net of current portion		—			—		—		0			—			—		—			—			—			—
Long term portion of finance lease liabilities		—			—		—		5,781			—			—		—			—			—			—
Contingent considerations, net of current portion		—			—		—		(0	)		—			—		—			—			—			—
Other liabilities		—			—		—		1,964			—			—		—			—			—			—
Total liabilities		(1,186,561	)		—		—		2,911,330			385			—		44			2,354			1,794			—
Stockholder’s Equity/Members’ Capital
Shares of Class A common stock $0.0001 par value		25			—		—		—			—			—		—			—			—			—
Shares of Class B common stock $0.0001 par value		31			—		—		—			—			—		—			—			—			—
Members’ capital		1,657			—		—		154,669			—			—		—			—			—			—
Additional paid-in capital		1,062,339			—		—		—			—			—		—			—			—			—
Accumulated deficit		122,509			—		—		(2,066,633	)		(278	)		—		(46	)		(2,355	)		(1,615	)		—
Total Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		1,186,561			—		—		(1,911,964	)		(278	)		—		(46	)		(2,355	)		(1,615	)		—
Total Liabilities and Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		(0	)		—		—		999,366			107			—		(2	)		(1	)		179			—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 9

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Balance Sheets (continued)   Case No: 24-10164 as of March 31, 2024 $ in thousands

Case Number	24-10174			24-10175		24-10176		24-10177		24-10178			24-10179		24-10180			24-10181		24-10182		24-10183
Entity	Comfort Pharmacy 2, LLC			Cano Medical Center of West Florida, LLC		Cano Occupational Health, LLC		CH Dental Administrative Services LLC		American Choice Healthcare, LLC			Physicians Partners Group Puerto Rico, LLC (FL)		DGM MSO, LLC			Cano PCP Wound Care, LLC		Cano Research LLC		Cano Personal Behavior LLC
Assets
Current assets:
Cash, cash equivalents and restricted cash		278			—		—		—		40,845			—		378			—		—		—
Accounts receivable, net of unpaid service provider costs		1,077			—		—		—		4,357			—		(22,180	)		—		—		—
Prepaid expenses and other current assets		(36	)		—		—		—		826			—		2			—		—		—
Total current assets		1,318			—		—		—		46,027			—		(21,799	)		—		—		—
Property and equipment, net		—			—		—		—		21			—		—			—		—		—
Operating lease right of use assets		—			—		—		—		—			—		—			—		—		—
Goodwill		—			—		—		—		—			—		—			—		—		—
Payor relationships, net		—			—		—		—		—			—		—			—		—		—
Other intangibles, net		—			—		—		—		—			—		—			—		—		—
Other assets		—			—		—		—		—			—		—			—		—		—
Total Assets		1,318			—		—		—		46,048			—		(21,799	)		—		—		—
Liabilities and stockholder’s equity
Current liabilities:
Accounts payable and accrued expenses		439			—		—		—		16,740			—		1,229			—		—		—
Current portion of notes payable		—			—		—		—		—			—		—			—		—		—
Current portion of finance lease liabilities		—			—		—		—		—			—		—			—		—		—
Current portion due to seller		—			—		—		—		—			—		—			—		—		—
Current portion of operating lease liabilities		(38	)		—		—		—		—			—		—			—		—		—
Other current liabilities		—			—		—		—		1,665			—		—			—		—		—
Intercompany		(2,140	)		—		—		—		36,256			—		(28,261	)		—		—		—
Total current liabilities		(1,739	)		—		—		—		54,661			—		(27,032	)		—		—		—
Notes payable, net of current portion and debt issuance costs		—			—		—		—		—			—		—			—		—		—
Long term portion of operating lease liabilities		—			—		—		—		—			—		—			—		—		—
Due to seller, net of current portion		—			—		—		—		—			—		—			—		—		—
Long term portion of finance lease liabilities		—			—		—		—		—			—		—			—		—		—
Contingent considerations, net of current portion		—			—		—		—		—			—		—			—		—		—
Other liabilities		—			—		—		—		—			—		—			—		—		—
Total liabilities		(1,739	)		—		—		—		54,661			—		(27,032	)		—		—		—
Stockholder’s Equity/Members’ Capital
Shares of Class A common stock $0.0001 par value		—			—		—		—		—			—		—			—		—		—
Shares of Class B common stock $0.0001 par value		—			—		—		—		—			—		—			—		—		—
Members’ capital		—			—		—		—		—			—		—			—		—		—
Additional paid-in capital		—			—		—		—		—			—		—			—		—		—
Accumulated deficit		3,057			—		—		—		(8,614	)		—		5,232			—		—		—
Total Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		3,057			—		—		—		(8,614	)		—		5,232			—		—		—
Total Liabilities and Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		1,318			—		—		—		46,048			—		(21,799	)		—		—		—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 10

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al.	Case No: 24-10164
Debtor Balance Sheets (continued)	as of March 31, 2024
	$ in thousands

Case Number	24-10184			24-10185			24-10186			24-10187		24-10188		24-10189		24-10190			24-10191		24-10192			24-10193
Entity	Cano PCP MSO, LLC			Physicians Partners Group Puerto Rico, LLC (PR)			Cano HP MSO, LLC			Cano PCP, LLC		Orange Healthcare Administration, LLC		ACH Management Services, LLC		Physicians Partners Group of FL, LLC			Cano Behavior Health LLC		PPG Puerto Rico Blocker, Inc.			Orange Care Group South Florida Management Services Organization, LLC
Assets
Current assets:
Cash, cash equivalents and restricted cash		—			47			—			—		—		—		—			—		—			—
Accounts receivable, net of unpaid service provider costs		—			901			14,962			—		—		—		(2,094	)		—		—			—
Prepaid expenses and other current assets		19			1,737			9			—		—		—		—			—		—			—
Total current assets		19			2,685			14,971			—		—		—		(2,094	)		—		—			—
Property and equipment, net		—			49			—			—		—		—		—			—		—			—
Operating lease right of use assets		—			(1	)		—			—		—		—		—			—		—			—
Goodwill		—			—			—			—		—		—		—			—		—			—
Payor relationships, net		—			—			—			—		—		—		—			—		—			—
Other intangibles, net		—			—			—			—		—		—		—			—		—			—
Other assets		—			7			—			—		—		—		—			—		—			—
Total Assets		19			2,740			14,971			—		—		—		(2,094	)		—		—			—
Liabilities and stockholder’s equity
Current liabilities:
Accounts payable and accrued expenses		0			(46	)		6,966			—		—		—		1,734			—		—			—
Current portion of notes payable		—			—			—			—		—		—		—			—		—			—
Current portion of finance lease liabilities		—			—			—			—		—		—		—			—		—			—
Current portion due to seller		—			—			—			—		—		—		—			—		—			—
Current portion of operating lease liabilities		—			(5	)		—			—		—		—		—			—		—			—
Other current liabilities		—			142			—			—		—		—		—			—		—			—
Intercompany		112			6,918			(6,405	)		—		—		—		(972	)		—		6			—
Total current liabilities		112			7,010			561			—		—		—		761			—		6			—
Notes payable, net of current portion and debt issuance costs		—			—			—			—		—		—		—			—		—			—
Long term portion of operating lease liabilities		—			(1	)		—			—		—		—		—			—		—			—
Due to seller, net of current portion		—			—			—			—		—		—		—			—		—			—
Long term portion of finance lease liabilities		—			—			—			—		—		—		—			—		—			—
Contingent considerations, net of current portion		—			—			—			—		—		—		—			—		—			—
Other liabilities		—			9			—			—		—		—		—			—		—			—
Total liabilities		112			7,017			561			—		—		—		761			—		6			—
Stockholder’s Equity/Members’ Capital
Shares of Class A common stock $0.0001 par value		—			—			—			—		—		—		—			—		—			—
Shares of Class B common stock $0.0001 par value		—			—			—			—		—		—		—			—		—			—
Members’ capital		—			—			—			—		—		—		—			—		—			—
Additional paid-in capital		—			—			—			—		—		—		—			—		—			—
Accumulated deficit		(93	)		(4,277	)		14,410			—		—		—		(2,855	)		—		(6	)		—
Total Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		(93	)		(4,277	)		14,410			—		—		—		(2,855	)		—		(6	)		—
Total Liabilities and Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		19			2,740			14,971			—		—		—		(2,094	)		—		—			—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 11

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Balance Sheets (continued) Case No: 24-10164 as of March 31, 2024 $ in thousands

Case Number	24-10194		24-10195		24-10196		24-10197			24-10198			24-10199		24-10200			24-10201		24-10202			24-10203
Entity	Cano Belen, LLC		Cano Health Illinois Network, LLC		Orange Accountable Care Organization of South Florida LLC		Cano Health New Mexico LLC			Cano Pharmacy, LLC			Orange Accountable Care Organization, LLC		IFB Pharmacy, LLC			American Choice Commercial ACO, LLC		Belen Pharmacy Group, LLC			Orange Care IPA of New York, LLC
Assets
Current assets:
Cash, cash equivalents and restricted cash		—		—		—		9			980			—		9			—		0			—
Accounts receivable, net of unpaid service provider costs		—		—		—		(251	)		1,676			—		114			—		229			—
Prepaid expenses and other current assets		—		—		—		16			727			—		0			—		(19	)		—
Total current assets		—		—		—		(227	)		3,383			—		123			—		210			—
Property and equipment, net		—		—		—		—			103			—		9			—		3			—
Operating lease right of use assets		—		—		—		15			(187	)		—		—			—		(39	)		—
Goodwill		—		—		—		—			—			—		—			—		—			—
Payor relationships, net		—		—		—		—			—			—		—			—		—			—
Other intangibles, net		—		—		—		—			—			—		—			—		—			—
Other assets		—		—		—		—			—			—		—			—		—			—
Total Assets		—		—		—		(212	)		3,299			—		131			—		174			—
Liabilities and stockholder’s equity
Current liabilities:
Accounts payable and accrued expenses		—		—		—		58			593			—		(0	)		—		0			—
Current portion of notes payable		—		—		—		—			—			—		—			—		—			—
Current portion of finance lease liabilities		—		—		—		31			—			—		—			—		—			—
Current portion due to seller		—		—		—		—			—			—		—			—		—			—
Current portion of operating lease liabilities		—		—		—		113			28			—		—			—		(29	)		—
Other current liabilities		—		—		—		—			—			—		—			—		—			—
Intercompany		—		—		—		13,128			11,104			—		1,099			—		1,397			—
Total current liabilities		—		—		—		13,329			11,725			—		1,099			—		1,368			—
Notes payable, net of current portion and debt issuance costs		—		—		—		—			—			—		—			—		—			—
Long term portion of operating lease liabilities		—		—		—		19			(211	)		—		—			—		(12	)		—
Due to seller, net of current portion		—		—		—		—			—			—		—			—		—			—
Long term portion of finance lease liabilities		—		—		—		49			—			—		—			—		—			—
Contingent considerations, net of current portion		—		—		—		—			—			—		—			—		—			—
Other liabilities		—		—		—		—			(39	)		—		—			—		—			—
Total liabilities		—		—		—		13,398			11,475			—		1,099			—		1,356			—
Stockholder’s Equity/Members’ Capital
Shares of Class A common stock $0.0001 par value		—		—		—		—			—			—		—			—		—			—
Shares of Class B common stock $0.0001 par value		—		—		—		—			—			—		—			—		—			—
Members’ capital		—		—		—		—			—			—		—			—		—			—
Additional paid-in capital		—		—		—		—			—			—		—			—		—			—
Accumulated deficit		—		—		—		(13,610	)		(8,175	)		—		(968	)		—		(1,182	)		—
Total Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		—		—		—		(13,610	)		(8,175	)		—		(968	)		—		(1,182	)		—
Total Liabilities and Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		—		—		—		(212	)		3,299			—		131			—		174			—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 12

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Balance Sheets (continued) Case No: 24-10164 as of March 31, 2024 $ in thousands

Case Number	24-10204			24-10205		24-10206		24-10207		24-10208		24-10209		24-10210		24-10211
Entity	University Health Care Pharmacy, LLC			Orange Care IPA of New Jersey, LLC		Cano Health New York, IPA, LLC		Total Care ACO, LLC		Clinical Research of Hollywood, P.A.		Cano Health CA1, LLC		Cano Health Illinois 1 MSO, LLC		Solis Network Solutions, LLC
Assets
Current assets:
Cash, cash equivalents and restricted cash		21			—		—		—		—		—		—		—
Accounts receivable, net of unpaid service provider costs		1,305			—		—		—		—		—		—		—
Prepaid expenses and other current assets		139			—		—		—		—		—		—		—
Total current assets		1,466			—		—		—		—		—		—		—
Property and equipment, net		—			—		—		—		—		—		—		—
Operating lease right of use assets		(165	)		—		—		—		—		—		—		—
Goodwill		—			—		—		—		—		—		—		—
Payor relationships, net		—			—		—		—		—		—		—		—
Other intangibles, net		—			—		—		—		—		—		—		—
Other assets		—			—		—		—		—		—		—		—
Total Assets		1,300			—		—		—		—		—		—		—
Liabilities and stockholder’s equity
Current liabilities:
Accounts payable and accrued expenses		13			—		—		—		—		—		—		—
Current portion of notes payable		—			—		—		—		—		—		—		—
Current portion of finance lease liabilities		—			—		—		—		—		—		—		—
Current portion due to seller		—			—		—		—		—		—		—		—
Current portion of operating lease liabilities		16			—		—		—		—		—		—		—
Other current liabilities		—			—		—		—		—		—		—		—
Intercompany		2,629			—		—		—		—		—		—		—
Total current liabilities		2,659			—		—		—		—		—		—		—
Notes payable, net of current portion and debt issuance costs		—			—		—		—		—		—		—		—
Long term portion of operating lease liabilities		(77	)		—		—		—		—		—		—		—
Due to seller, net of current portion		—			—		—		—		—		—		—		—
Long term portion of finance lease liabilities		—			—		—		—		—		—		—		—
Contingent considerations, net of current portion		—			—		—		—		—		—		—		—
Other liabilities		—			—		—		—		—		—		—		—
Total liabilities		2,581			—		—		—		—		—		—		—
Stockholder’s Equity/Members’ Capital
Shares of Class A common stock $0.0001 par value		—			—		—		—		—		—		—		—
Shares of Class B common stock $0.0001 par value		—			—		—		—		—		—		—		—
Members’ capital		—			—		—		—		—		—		—		—
Additional paid-in capital		—			—		—		—		—		—		—		—
Accumulated deficit		(1,281	)		—		—		—		—		—		—		—
Total Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		(1,281	)		—		—		—		—		—		—		—
Total Liabilities and Stockholders’ Equity (Deficit) / Members’ Capital (Deficit)		1,300			—		—		—		—		—		—		—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 13

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Statement of Income (Loss) Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10164			24-10165		24-10166		24-101671			24-10168			24-10169		24-10170		24-10171			24-10172		24-10173
	Cano Health, Inc.			Primary Care (ITC) Intermediate Holdings, LLC		Complete Medical Billing and Coding Services, LLC		Cano Health, LLC			Cano Health of Puerto Rico LLC			CHPR MSO LLC		Cano Health of Florida, LLC		Cano Health CA1 MSO, LLC			Physicians Partners Group Merger, LLC		Cano Health Nevada Network, LLC
Revenues
Capitated revenue		—			—		—		91,205			—			—		—		—			—		—
Fee-for-service and other revenue		—			—		—		1,363			—			—		—		—			—		—
Total Revenues		—			—		—		92,568			—			—		—		—			—		—
Operating Expenses
Third-party medical costs		—			—		—		92,019			—			—		—		—			—		—
Direct patient expense		—			—		—		6,659			—			—		—		—			—		—
Selling, general and administrative expense		3,299			—		—		20,581			1			—		—		0			—		—
Depreciation and amortization expense		—			—		—		6,105			—			—		—		—			—		—
Transaction costs and other		—			—		—		564			—			—		—		—			—		—
Fair value adjustment - contingent considerations		—			—		—		—			—			—		—		—			—		—
Credit loss on other assets		—			—		—		—			—			—		—		—			—		—
Goodwill impairment loss		—			—		—		—			—			—		—		—			—		—
Total Operating Expenses		3,299			—		—		125,929			1			—		—		0			—		—
Income (loss) from Operations		(3,299	)		—		—		(33,361	)		(1	)		—		—		(0	)		—		—
Other (Expense) Income
Interest expense		—			—		—		(2,674	)		—			—		—		—			—		—
Interest income		—			—		—		14			—			—		—		—			—		—
Loss on extinguishment of debt		—			—		—		—			—			—		—		—			—		—
Change in fair value of warrant liabilities		—			—		—		—			—			—		—		—			—		—
Other expenses		—			—		—		24			—			—		—		—			—		—
Reorganization expense		—			—		—		(62,344	)		—			—		—		—			—		—
Total Other Expenses, Net		—			—		—		(64,981	)		—			—		—		—			—		—
Income tax expense (benefit)		—			—		—		—			—			—		—		—			—		—
Net Income (loss)		(3,299	)		—		—		(98,342	)		(1	)		—		—		(0	)		—		—

Footnote:

1. The Debtors have prepared the financial information for the purposes of this MOR prior to receiving two pending journal entries related to (i) an anticipated tax receivable charge related to its TRA liability, and (ii) a liability reversal of its contingent consideration on deferred compensation.

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 14

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Statement of Income (Loss) (continued)   Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10174	24-10175	24-10176	24-10177	24-10178		24-10179	24-10180		24-10181	24-10182	24-10183
	Comfort Pharmacy 2, LLC	Cano Medical Center of West Florida, LLC	Cano Occupational Health, LLC	CH Dental Administrative Services LLC	American Choice Healthcare, LLC		Physicians Partners Group Puerto Rico, LLC (FL)	DGM MSO, LLC		Cano PCP Wound Care, LLC	Cano Research LLC	Cano Personal Behavior LLC
Revenues
Capitated revenue	—	—	—	—	100,327		—	9,153		—	—	—
Fee-for-service and other revenue	772	—	—	—	—		—	0		—	—	—
Total Revenues	772	—	—	—	100,327		—	9,153		—	—	—
Operating Expenses
Third-party medical costs	—	—	—	—	101,466		—	9,845		—	—	—
Direct patient expense	739	—	—	—	1,845		—	277		—	—	—
Selling, general and administrative expense	1	—	—	—	142		—	0		—	—	—
Depreciation and amortization expense	—	—	—	—	1		—	—		—	—	—
Transaction costs and other	—	—	—	—	—		—	—		—	—	—
Fair value adjustment - contingent considerations	—	—	—	—	—		—	—		—	—	—
Credit loss on other assets	—	—	—	—	—		—	—		—	—	—
Goodwill impairment loss	—	—	—	—	—		—	—		—	—	—
Total Operating Expenses	741	—	—	—	103,455		—	10,122		—	—	—
Income (loss) from Operations	31	—	—	—	(3,127	)	—	(969	)	—	—	—
Other (Expense) Income
Interest expense	—	—	—	—	—		—	—		—	—	—
Interest income	—	—	—	—	458		—	—		—	—	—
Loss on extinguishment of debt	—	—	—	—	—		—	—		—	—	—
Change in fair value of warrant liabilities	—	—	—	—	—		—	—		—	—	—
Other expenses	—	—	—	—	77		—	—		—	—	—
Reorganization expense	—	—	—	—	—		—	—		—	—	—
Total Other Expenses, Net	—	—	—	—	534		—	—		—	—	—
Income tax expense (benefit)	—	—	—	—	—		—	—		—	—	—
Net Income (loss)	31	—	—	—	(2,593	)	—	(969	)	—	—	—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 15

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Statement of Income (Loss) (continued) Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10184		24-10185			24-10186			24-10187		24-10188		24-10189		24-10190		24-10191		24-10192		24-10193
	Cano PCP MSO, LLC		Physicians Partners Group Puerto Rico, LLC (PR)			Cano HP MSO, LLC			Cano PCP, LLC		Orange Healthcare Administration, LLC		ACH Management Services, LLC		Physicians Partners Group of FL, LLC		Cano Behavior Health LLC		PPG Puerto Rico Blocker, Inc.		Orange Care Group South Florida Management Services Organization, LLC
Revenues
Capitated revenue		—		—			26,890			—		—		—		2,944		—		—		—
Fee-for-service and other revenue		—		—			—			—		—		—		—		—		—		—
Total Revenues		—		—			26,890			—		—		—		2,944		—		—		—
Operating Expenses
Third-party medical costs		—		(1,437	)		29,474			—		—		—		2,075		—		—		—
Direct patient expense		—		—			3,518			—		—		—		—		—		—		—
Selling, general and administrative expense		—		1			10			—		—		—		—		—		—		—
Depreciation and amortization expense		—		—			—			—		—		—		—		—		—		—
Transaction costs and other		—		—			—			—		—		—		—		—		—		—
Fair value adjustment - contingent considerations		—		—			—			—		—		—		—		—		—		—
Credit loss on other assets		—		—			—			—		—		—		—		—		—		—
Goodwill impairment loss		—		—			—			—		—		—		—		—		—		—
Total Operating Expenses		—		(1,436	)		33,002			—		—		—		2,075		—		—		—
Income (loss) from Operations		—		1,436			(6,112	)		—		—		—		869		—		—		—
Other (Expense) Income
Interest expense		—		—			—			—		—		—		—		—		—		—
Interest income		—		—			—			—		—		—		—		—		—		—
Loss on extinguishment of debt		—		—			—			—		—		—		—		—		—		—
Change in fair value of warrant liabilities		—		—			—			—		—		—		—		—		—		—
Other expenses		—		(18	)		—			—		—		—		—		—		—		—
Reorganization expense		—		—			—			—		—		—		—		—		—		—
Total Other Expenses, Net		—		(18	)		—			—		—		—		—		—		—		—
Income tax expense (benefit)		—		—			—			—		—		—		—		—		—		—
Net Income (loss)		—		1,418			(6,112	)		—		—		—		869		—		—		—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 16

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Statement of Income (Loss) (continued) Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10194		24-10195		24-10196		24-10197			24-10198			24-10199		24-10200			24-10201		24-10202			24-10203
	Cano Belen, LLC		Cano Health Illinois Network, LLC		Orange Accountable Care Organization of South Florida LLC		Cano Health New Mexico LLC			Cano Pharmacy, LLC			Orange Accountable Care Organization, LLC		IFB Pharmacy, LLC			American Choice Commercial ACO, LLC		Belen Pharmacy Group, LLC			Orange Care IPA of New York, LLC
Revenues
Capitated revenue		—		—		—		—			—			—		—			—		—			—
Fee-for-service and other revenue		—		—		—		1			2,038			—		—			—		—			—
Total Revenues		—		—		—		1			2,038			—		—			—		—			—
Operating Expenses
Third-party medical costs		—		—		—		—			—			—		—			—		—			—
Direct patient expense		—		—		—		—			1,884			—		(0	)		—		(0	)		—
Selling, general and administrative expense		—		—		—		7			246			—		2			—		13			—
Depreciation and amortization expense		—		—		—		—			8			—		0			—		0			—
Transaction costs and other		—		—		—		—			—			—		—			—		—			—
Fair value adjustment - contingent considerations		—		—		—		—			—			—		—			—		—			—
Credit loss on other assets		—		—		—		—			—			—		—			—		—			—
Goodwill impairment loss		—		—		—		—			—			—		—			—		—			—
Total Operating Expenses		—		—		—		7			2,138			—		2			—		13			—
Income (loss) from Operations		—		—		—		(6	)		(100	)		—		(2	)		—		(13	)		—
Other (Expense) Income
Interest expense		—		—		—		—			—			—		—			—		—			—
Interest income		—		—		—		—			—			—		—			—		—			—
Loss on extinguishment of debt		—		—		—		—			—			—		—			—		—			—
Change in fair value of warrant liabilities		—		—		—		—			—			—		—			—		—			—
Other expenses		—		—		—		(9	)		—			—		—			—		—			—
Reorganization expense		—		—		—		2,439			—			—		—			—		—			—
Total Other Expenses, Net		—		—		—		2,430			—			—		—			—		—			—
Income tax expense (benefit)		—		—		—		—			—			—		—			—		—			—
Net Income (loss)		—		—		—		2,424			(100	)		—		(2	)		—		(13	)		—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 17

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Debtor Statement of Income (Loss) (continued) Case No: 24-10164 Reporting Period: March 1 – March 31, 2024 $ in thousands

Case Number	24-10204			24-10205		24-10206		24-10207		24-10208		24-10209		24-10210		24-10211
	University Health Care Pharmacy, LLC			Orange Care IPA of New Jersey, LLC		Cano Health New York, IPA, LLC		Total Care ACO, LLC		Clinical Research of Hollywood, P.A.		Cano Health CA1, LLC		Cano Health Illinois 1 MSO, LLC		Solis Network Solutions, LLC
Revenues
Capitated revenue		—			—		—		—		—		—		—		—
Fee-for-service and other revenue		584			—		—		—		—		—		—		—
Total Revenues		584			—		—		—		—		—		—		—
Operating Expenses
Third-party medical costs		—			—		—		—		—		—		—		—
Direct patient expense		744			—		—		—		—		—		—		—
Selling, general and administrative expense		10			—		—		—		—		—		—		—
Depreciation and amortization expense		—			—		—		—		—		—		—		—
Transaction costs and other		—			—		—		—		—		—		—		—
Fair value adjustment - contingent considerations		—			—		—		—		—		—		—		—
Credit loss on other assets		—			—		—		—		—		—		—		—
Goodwill impairment loss		—			—		—		—		—		—		—		—
Total Operating Expenses		754			—		—		—		—		—		—		—
Income (loss) from Operations		(170	)		—		—		—		—		—		—		—
Other (Expense) Income
Interest expense		—			—		—		—		—		—		—		—
Interest income		—			—		—		—		—		—		—		—
Loss on extinguishment of debt		—			—		—		—		—		—		—		—
Change in fair value of warrant liabilities		—			—		—		—		—		—		—		—
Other expenses		—			—		—		—		—		—		—		—
Reorganization expense		—			—		—		—		—		—		—		—
Total Other Expenses, Net		—			—		—		—		—		—		—		—
Income tax expense (benefit)		—			—		—		—		—		—		—		—
Net Income (loss)		(170	)		—		—		—		—		—		—		—

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 18

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Schedule of Post-Petition Borrowing Activity Case No: 24-10164 Reporting Period: March 1 – March 31, 2024

The Debtors hereby submit this attestation regarding postpetition borrowing during the period of March 1 through March 31, 2024.

In accordance with the Debtors’ FINAL ORDER PURSUANT TO 11 U.S.C. §§ 105, 361, 362, 363, 364, 507, AND 552 AND FED. R. BANKR. P. 2002, 4001, 6003, 6004, AND 9014 FOR (I) AUTHORITY TO (A) OBTAIN POSTPETITION FINANCING, (B) USE CASH COLLATERAL (C) GRANT LIENS AND PROVIDE SUPERPRIORITY ADMINISTRATIVE EXPENSE STATUS, (D) GRANT ADEQUATE PROTECTION, AND (E) MODIFY THE AUTOMATIC STAY, AND (II) RELATED RELIEF [Docket No. 271], Debtor Cano Health, LLC, initiated the following borrowing during this reporting period, which was deposited to Cano Health, LLC account *7721:

$22,000,000 on March 18, 2024

/s/ Eladio Gil	May 1, 2024
Signature of Authorized Individual	Date
Eladio Gil	Chief Financial Officer
Printed Name of Authorized Individual	Title of Authorized Individual

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 19

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Schedule of Payments on Prepetition Debt Case No: 24-10164 Reporting Period: March 1 – March 31, 2024

All payments made by the Debtors during the Reporting Period (and included in the disbursements reported in this MOR) were authorized under various final orders granted by the Court, which authorized the Debtors’ various motions that were filed following the commencement of the Chapter 11 Cases.

/s/ Eladio Gil	May 1, 2024
Signature of Authorized Individual	Date
Eladio Gil	Chief Financial Officer
Printed Name of Authorized Individual	Title of Authorized Individual

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 20

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. Schedule of Payments to Insiders Case No: 24-10164 Reporting Period: March 1 – March 31, 2024

The Debtors hereby submit this attestation regarding payments to insiders during the period of March 1 through March 31, 2024.

With respect to insiders, all cash payments made were on account of ordinary course salaries and authorized travel and expense reimbursements.

No non-cash transfers were made during this reporting period.

/s/ Eladio Gil	May 1, 2024
Signature of Authorized Individual	Date
Eladio Gil	Chief Financial Officer
Printed Name of Authorized Individual	Title of Authorized Individual

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 21

UNITED STATES BANKRUPTCY COURT

DISTRICT OF DELAWARE

In re: Cano Health, Inc., et al. All bank statements and bank reconciliations for the reporting period Case No: 24-10164 Reporting Period: March 1 – March 31, 2024

The Debtors hereby submit this attestation regarding bank account reconciliations in lieu of providing copies of bank statements, bank reconciliations, and journal entries.

The Debtors’ standard practice is to ensure that bank reconciliations are completed as part of the month end close each reporting period. I attest that each of the Debtors’ bank accounts has been reconciled in accordance with their standard practices.

/s/ Eladio Gil	May 1, 2024
Signature of Authorized Individual	Date
Eladio Gil	Chief Financial Officer
Printed Name of Authorized Individual	Title of Authorized Individual

Official MOR Form Monthly Operating Report About Debtor Entities’ Value, Operations, Profitability and Cash Flows 22

XML

Document and Entity Information	May 01, 2024
Cover [Abstract]
Security Exchange Name	NONE
Amendment Flag	false
Entity Central Index Key	0001800682
Document Type	8-K
Document Period End Date	May 01, 2024
Entity Registrant Name	Cano Health, Inc.
Entity File Number	001-39289
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	98-1524224
Entity Address, Address Line One	9725 NW 117th Avenue
Entity Address, City or Town	Miami
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33178
City Area Code	855
Local Phone Number	226-6633
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Security 12b Title	Class A common stock, $0.01 par value per share
Trading Symbol	CANOQ
Entity Emerging Growth Company	false